Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 789298, 8 pages
http://dx.doi.org/10.1155/2015/789298
Research Article

Prognostic Implications of Serum Lipid Metabolism over Time during Sepsis

1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Institute of Chest Diseases, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Republic of Korea
2Division of Respiratory and Critical Care Medicine, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, 73 Inchon-ro, Seongbuk-gu, Seoul 136-705, Republic of Korea

Received 9 June 2015; Revised 27 July 2015; Accepted 28 July 2015

Academic Editor: Anastasia Kotanidou

Copyright © 2015 Sang Hoon Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K.-M. Kaukonen, M. Bailey, S. Suzuki, D. Pilcher, and R. Bellomo, “Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000–2012,” Journal of the American Medical Association, vol. 311, no. 13, pp. 1308–1316, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Lagu, M. B. Rothberg, M.-S. Shieh, P. S. Pekow, J. S. Steingrub, and P. K. Lindenauer, “Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007,” Critical Care Medicine, vol. 40, no. 3, pp. 754–761, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. D. C. Angus and T. van der Poll, “Severe sepsis and septic shock,” The New England Journal of Medicine, vol. 369, no. 21, p. 2063, 2013. View at Google Scholar · View at Scopus
  4. A. Cetinkaya, A. Erden, D. Avci et al., “Is hypertriglyceridemia a prognostic factor in sepsis?” Therapeutics and Clinical Risk Management, vol. 10, no. 1, pp. 147–150, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. H. J. Van Leeuwen, E. C. J. M. Heezius, G. M. Dallinga, J. A. G. van Strijp, J. Verhoef, and K. P. M. van Kessel, “Lipoprotein metabolism in patients with severe sepsis,” Critical Care Medicine, vol. 31, no. 5, pp. 1359–1366, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. A. M. Barcia and H. W. Harris, “Triglyceride-rich lipoproteins as agents of innate immunity,” Clinical Infectious Diseases, vol. 41, no. 7, pp. S498–S503, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. A. H. Wu, C. J. Hinds, and C. Thiemermann, “High-density lipoproteins in sepsis and septic shock: metabolism, actions, and therapeutic applications,” Shock, vol. 21, no. 3, pp. 210–221, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. O. Murch, M. Collin, C. J. Hinds, and C. Thiemermann, “Lipoproteins in inflammation and sepsis. I. Basic science,” Intensive Care Medicine, vol. 33, no. 1, pp. 13–24, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Wendel, R. Paul, and A. R. Heller, “Lipoproteins in inflammation and sepsis. II. Clinical aspects,” Intensive Care Medicine, vol. 33, no. 1, pp. 25–35, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Chenaud, P. G. Merlani, P. Roux-Lombard et al., “Low apolipoprotein A-I level at intensive care unit admission and systemic inflammatory response syndrome exacerbation,” Critical Care Medicine, vol. 32, no. 3, pp. 632–637, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. D. F. McAuley, J. G. Laffey, C. M. O'Kane et al., “Simvastatin in the acute respiratory distress syndrome,” The New England Journal of Medicine, vol. 371, no. 18, pp. 1695–1703, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. J. D. Truwit, G. R. Bernard, J. Steingrub et al., “Rosuvastatin for sepsis-associated acute respiratory distress syndrome,” The New England Journal of Medicine, vol. 370, no. 23, pp. 2191–2200, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. B. R. Gordon, T. S. Parker, D. M. Levine et al., “Relationship of hypolipidemia to cytokine concentrations and outcomes in critically ill surgical patients,” Critical Care Medicine, vol. 29, no. 8, pp. 1563–1568, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. C. L. Vermont, M. den Brinker, N. Kâkeci et al., “Serum lipids and disease severity in children with severe meningococcal sepsis,” Critical Care Medicine, vol. 33, no. 7, pp. 1610–1615, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. R. C. Bone, R. A. Balk, F. B. Cerra et al., “American-College of Chest Physicians Society of Critical Care Medicine Consensus Conference—definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis,” Critical Care Medicine, vol. 20, no. 6, pp. 864–874, 1992. View at Google Scholar
  16. M. M. Levy, M. P. Fink, J. C. Marshall et al., “2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference,” Critical Care Medicine, vol. 31, no. 4, pp. 1250–1256, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Calandra and J. Cohen, “The international sepsis forum consensus conference on definitions of infection in the intensive care unit,” Critical Care Medicine, vol. 33, no. 7, pp. 1538–1548, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. R. P. Dellinger, M. M. Levy, J. M. Carlet et al., “Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008,” Intensive Care Medicine, vol. 34, no. 1, pp. 17–60, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. H. J. Van Leeuwen, E. C. J. M. Heezius, G. M. Dallinga, J. A. G. van Strijp, J. Verhoef, and K. P. M. van Kessel, “ESPEN guidelines for nutrition screening 2002,” Clinical Nutrition, vol. 22, no. 4, pp. 415–421, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. “Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients,” Journal of Parenteral and Enteral Nutrition, vol. 26, no. 1, supplement, pp. 1SA–138SA, 2002. View at Publisher · View at Google Scholar
  21. P. A. Goldberg, M. D. Siegel, R. S. Sherwin et al., “Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit,” Diabetes Care, vol. 27, no. 2, pp. 461–467, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. J.-Y. Chien, J.-S. Jerng, C.-J. Yu, and P.-C. Yang, “Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis,” Critical Care Medicine, vol. 33, no. 8, pp. 1688–1693, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Barlage, C. Gnewuch, G. Liebisch et al., “Changes in HDL-associated apolipoproteins relate to mortality in human sepsis and correlate to monocyte and platelet activation,” Intensive Care Medicine, vol. 35, no. 11, pp. 1877–1885, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Guo, J. T. Ai, Z. Zheng et al., “High density lipoprotein protects against polymicrobe-induced sepsis in mice,” The Journal of Biological Chemistry, vol. 288, no. 25, pp. 17947–17953, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. M. C. McDonald, P. Dhadly, G. W. Cockerill et al., “Reconstituted high-density lipoprotein attenuates organ injury and adhesion molecule expression in a rodent model of endotoxic shock,” Shock, vol. 20, no. 6, pp. 551–557, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. H. W. Harris, C. Grunfeld, K. R. Feingold, and J. H. Rapp, “Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice,” The Journal of Clinical Investigation, vol. 86, no. 3, pp. 696–702, 1990. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Chiarla, I. Giovannini, F. Giuliante et al., “Severe hypocholesterolemia in surgical patients, sepsis, and critical illness,” Journal of Critical Care, vol. 25, no. 2, pp. 361.e7–361.e12, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. K.-H. Choi, M.-S. Park, J.-T. Kim et al., “Serum triglyceride level is an important predictor of early prognosis in patients with acute ischemic stroke,” Journal of the Neurological Sciences, vol. 319, no. 1-2, pp. 111–116, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Janda, A. Young, J. M. FitzGerald, M. Etminan, and J. Swiston, “The effect of statins on mortality from severe infections and sepsis: a systematic review and meta-analysis,” Journal of Critical Care, vol. 25, no. 4, pp. 656.e7–656.e22, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Kopterides and M. E. Falagas, “Statins for sepsis: a critical and updated review,” Clinical Microbiology and Infection, vol. 15, no. 4, pp. 325–334, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. I. M. Tleyjeh, T. Kashour, F. A. Hakim et al., “Statins for the prevention and treatment of infections: a systematic review and meta-analysis,” Archives of Internal Medicine, vol. 169, no. 18, pp. 1658–1667, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Mesotten, J. V. Swinnen, F. Vanderhoydonc, P. J. Wouters, and G. Van Den Berghe, “Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 1, pp. 219–226, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. Z. Li, H. Wang, B. Chen, and G. Li, “Serum soluble triggering receptor expressed on myeloid cells-1 and procalcitonin can reflect sepsis severity and predict prognosis: a prospective cohort study,” Mediators of Inflammation, vol. 2014, Article ID 641039, 7 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Phua, E. S. C. Koay, and K. H. Lee, “Lactate, procalcitonin, and amino-terminal pro-B-type natriuretic peptide versus cytokine measurements and clinical severity scores for prognostication in septic shock,” Shock, vol. 29, no. 3, pp. 328–333, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. J.-M. Cavaillon, C. Fitting, N. Haeffner-Cavaillon, S. J. Kirsch, and H. S. Warren, “Cytokine response by monocytes and macrophages to free and lipoprotein-bound lipopolysaccharide,” Infection and Immunity, vol. 58, no. 7, pp. 2375–2382, 1990. View at Google Scholar · View at Scopus
  36. B. Beutler and A. Cerami, “Cachectin and tumour necrosis factor as two sides of the same biological coin,” Nature, vol. 320, no. 6063, pp. 584–588, 1986. View at Publisher · View at Google Scholar · View at Scopus